AI In Pathology Market Size Worth USD 113.02 Billion by 2034 | CAGR: 15.1%

The AI in Pathology market size is expected to reach USD  113.02 Billion by 2034, according to a new study by Polaris Market Research. The report “AI In Pathology Market Size, Share, Trends, Industry Analysis Report By Offering, By Neural Network, By Function, By Use Case, By End User, By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The AI in Pathology market is witnessing strong growth driven by the rising prevalence of cancer and chronic diseases, the growing adoption of digital pathology, and increasing demand for accurate and efficient diagnostic solutions.

Request a free sample copy or read the full market insights: AI In Pathology Market Report

Advancements in deep learning, computer vision, and image analysis are accelerating diagnostic workflows and improving precision in disease detection. Leading players are focusing on developing scalable and interoperable AI-driven pathology platforms that enhance diagnostic accuracy, support personalized medicine, and meet global healthcare innovation and digital transformation goals.

AI In Pathology Market Report Highlights

• Based on offering, the end-to-end solutions segment dominated the market in 2024, driven by their ability to provide comprehensive support across the entire pathology workflow from image acquisition to diagnostics and reporting.
• In terms of neural network type, the convolutional neural networks (CNN) segment held the largest share in 2024, owing to their proven accuracy in image recognition, segmentation, and classification tasks within digital pathology.
• By function, the image analysis segment led the market in 2024, fueled by growing adoption of AI tools to automate routine pathology tasks, minimize diagnostic errors, and improve laboratory throughput.
• Based on use case, the disease diagnosis and prognosis segment accounted for the largest share in 2024, supported by increasing demand for early and precise detection of cancer, infectious diseases, and chronic disorders.
• In terms of end user, the hospitals and reference laboratories segment dominated the market in 2024, driven by rapid implementation of AI-assisted digital pathology systems for both routine and complex diagnostic workflows.
• North America accounted for a significant share in 2024, supported by strong integration of digital pathology and AI-based diagnostic tools across healthcare and research institutions.
• The Asia Pacific market grew rapidly in 2024, fueled by expanding healthcare digitalization, increasing investments in AI infrastructure, and growing adoption of AI-driven pathology solutions across emerging economies.
• A few key global players include Aiforia Technologies Plc, Akoya Biosciences, Inc., Deep Bio Inc., Hologic, Inc., Ibex Medical Analytics Ltd., Indica Labs Inc., Koninklijke Philips N.V., Mindpeak GmbH, OptraScan, Inc., Paige AI, Inc., Proscia Inc., Techcyte, Inc., Tempus Labs, Inc., Tribun Health, and Visiopharm A/S.

Polaris Market Research has segmented the market report on the basis of offering, neural network, function, use case, end user, and region:

By Offering Outlook (Revenue, USD Billion, 2020–2034)

• End-to-End Solutions
• Niche Point Solutions
• Technology
• Hardware
• Microscopes
• Scanners
• Storage Systems

By Neural Network Outlook (Revenue, USD Billion, 2020–2034)

• Convolutional Neural Networks (CNNS)
• Generative Adversarial Networks (GANS)
• Recurrent Neural Networks (RNNS)
• Other Neural Networks

By Function Outlook (Revenue, USD Billion, 2020–2034)

• Image Analysis
• Diagnostics
• Workflow Management
• Data Management
• Predictive Analytics
• CDSS
• Automated Report Generation
• Quality Assurance Tools

By Use Case Outlook (Revenue, USD Billion, 2020–2034)

• Drug Discovery
• Disease Diagnosis & Prognosis
• Clinical Workflow
• Training & Education

By End User Outlook (Revenue, USD Billion, 2020–2034)

• Pharmaceutical & Biopharmaceutical Companies
• Hospitals & Reference Laboratories
• Academic & Research Institutes

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America

• US
• Canada

• Europe

• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe

• Asia Pacific

• China
• Japan
• India
• Malaysia
• South Korea
• Indonesia
• Australia
• Vietnam
• Rest of Asia Pacific

• Middle East & Africa

• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa

• Latin America

• Mexico
• Brazil
• Argentina
• Rest of Latin America